Z-1683-2023 Class II Ongoing

Recalled by Qiagen Sciences LLC — Germantown, MD

FDA device recall Z-1683-2023 was initiated by Qiagen Sciences LLC on Apr 28, 2023 and is designated Class II. Reason for recall: Faulty cartridges in the lot could result in false test results. The recall status is ongoing. Affected quantity: 347 kits.

Recall details

Product Type
Devices
Report Date
Jun 14, 2023
Initiation Date
Apr 28, 2023
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
347 kits

Product description

QIAstat-Dx Respiratory SARS-CoV-2 Panel multiplexed nucleic acid real-time PCR test, Reference Number 691223

Reason for recall

Faulty cartridges in the lot could result in false test results.

Distribution pattern

US Nationwide distribution in the states of CA, FL, IL, MD, MS, NY, OK, PA, TN.

Code information

GTIN 14053228038846; Lot 175011350; Serial Numbers within the range of 330568064 to SN 330568597 AND 330569655, 330569651, 330569650, 330569646, 330569645, 330569644, 330569643, 330569641.

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-1683-2023
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for Z-1683-2023. Report a data issue: hello@regdatalab.com.